Boston Scientific (NYSE: BSX) is resuming its “Avant Guard” study of pulse field ablation as a first-line therapy for persistent atrial fibrillation (AFib). The device developer paused the trial last month, with CEO Mike Mahoney citing the need to “assess a few unanticipated observations.” Boston Scientific said it did not halt the trial due to […]
atrial fibrillation
AtriCure posts Street-beating Q3 results, maintains full-year outlook
AtriCure (NSDQ:ATRC) posted third-quarter results today that beat the consensus forecast on Wall Street and maintained its outlook for the full year. The Mason, Ohio-based atrial fibrillation (AFib) technology developer reported profits of $97.1 million, or $2.11 per diluted share, on sales of $70.5 million for the three months ended Sept. 30. Sales grew 28.7% […]
FDA approves Abbott Amplatzer Amulet to reduce stroke risk for AFib patients
Abbott today announced that it has received FDA approval for its Amplatzer Amulet device for people with atrial fibrillation. The Amplatzer Amulet is a left atrial appendage occluder to reduce ischemic stroke risk for people with atrial fibrillation (AFib). The device is a small pouch connected to the upper left chamber of the heart. AFib […]
Volta Medical raises $28M for Afib treatment tech
Volta Medical announced this week that it raised $28 million in a financing round for its AI algorithms for treating cardiac arrhythmias. Marseille, France-based Volta Medical said in a news release that the $28 million, raised in a round led by Gilde Healthcare with participation from existing shareholder Pasteur Mutualité, will help the company establish […]
Livmor wins FDA nod for continuous heart monitoring wearable
Livmor announced today that it received FDA 510(k) clearance for its Livmor Halo wearable AFib detection system. Dallas-based Livmor’s Halo AFib detection system is a physician-prescribed wearable device for continuously monitoring pulse rhythms to detect AFib on-demand during the day and automatically overnight, according to a news release. Halo is deployed on a Samsung wearable […]
ESC Congress 2019: Biotronik beats Abbott at target lesion failure
Biotronik said yesterday that its Orsiro stent tops the Xience stents made by Abbott (NYSE:ABT) when it comes to target lesion failure, according to data from a clinical trial. The randomized, controlled BioSTEMI trial was the first direct comparison between the two drug-eluting stents in patients with acute ST-segment elevation myocardial infarction (STEMI). Biotronik announced […]
Thermedical wins FDA nod for Durablate catheter trial
Thermedical said today that it won an investigational device exemption from the FDA for a clinical trial of its Durablate catheter for treating ventricular tachycardia. The Durablate catheter is designed to simultaneously inject hot saline and use radiofrequency energy to effect the ablation; the Thermedical claims that the method is 20 times more effective than conventional RF […]
Apple Watch detects atrial fibrillation using built-in technology
The Apple Watch can automatically detect atrial fibrillation (AF) using its built-in heart rate sensor and artificial intelligence, according to a new study. The research used a deep neural network that was based on photoplethysmographic (PPG) sensors that are frequently found in smart watches. When paired with an artificial intelligence-based algorithm, Apple Watch’s heart rate […]
